SGLT2 inhibitors and GLP-1 receptor agonists are recommended treatments for T2DM in patients with cardiovascular (CV) or chronic kidney disease. A new systematic review and meta-analysis investigated ...
Poor nutrition is fundamental to most lifestyle diseases, including type 2 diabetes mellitus (T2DM). Therefore, adopting a healthy and nutritious diet can be pivotal for treating these patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback